Tirta M. Djajawi
Clayton, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
CRISPR screens define unified hallmarks of cancer cell-autonomous immune evasion.
Journal: Cell reports
Published: August 14, 2025
A TAK1 cytokine toxicity checkpoint controls anti-cancer immunity.
Journal: Cell reports
Published: May 22, 2025
Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteins.
Journal: Cell death and differentiation
Published: July 05, 2024
Divergent roles of RIPK3 and MLKL in high-fat diet-induced obesity and MAFLD in mice.
Journal: Life science alliance
Published: October 18, 2023
PRMT1 acts as a suppressor of MHC-I and anti-tumor immunity.
Journal: Cell reports
Published: September 08, 2023
Tumor immune evasion: insights from CRISPR screens and future directions.
Journal: The FEBS journal
Published: September 03, 2023
A1 is induced by pathogen ligands to limit myeloid cell death and NLRP3 inflammasome activation.
Journal: EMBO reports
Published: January 23, 2023
Candida auris uses metabolic strategies to escape and kill macrophages while avoiding robust activation of the NLRP3 inflammasome response.
Journal: Cell reports
Published: August 16, 2022
RIPK3 controls MAIT cell accumulation during development but not during infection.
Journal: Cell death & disease
Published: August 07, 2022
Mitochondrial E3 ubiquitin ligase MARCHF5 controls BAK apoptotic activity independently of BH3-only proteins.
Journal: Cell death and differentiation
Published: May 03, 2022
Last Updated: 09/26/2026